Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Baker Tilly Wealth Management LLC

Baker Tilly Wealth Management LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.8% in the 1st quarter, Holdings Channel.com reports. The fund owned 1,340 shares of the medical equipment provider’s stock after buying an additional 85 shares during the period. Baker Tilly Wealth Management LLC’s holdings in Intuitive Surgical were worth $664,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the business. Sycomore Asset Management boosted its stake in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Castleark Management LLC raised its holdings in shares of Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock worth $47,221,000 after buying an additional 2,990 shares during the last quarter. Truist Financial Corp lifted its stake in shares of Intuitive Surgical by 3.0% during the fourth quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider’s stock worth $129,494,000 after buying an additional 7,298 shares during the period. Global X Japan Co. Ltd. grew its holdings in shares of Intuitive Surgical by 9.8% during the fourth quarter. Global X Japan Co. Ltd. now owns 46,289 shares of the medical equipment provider’s stock valued at $24,161,000 after buying an additional 4,140 shares during the last quarter. Finally, Northeast Investment Management increased its position in shares of Intuitive Surgical by 3.1% in the 4th quarter. Northeast Investment Management now owns 89,170 shares of the medical equipment provider’s stock valued at $46,543,000 after acquiring an additional 2,685 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,695,113.84. This trade represents a 3.47% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. The trade was a 60.72% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 25,778 shares of company stock valued at $12,867,197. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $551.14 on Monday. Intuitive Surgical, Inc. has a one year low of $397.47 and a one year high of $616.00. The firm’s fifty day moving average is $516.44 and its 200 day moving average is $538.55. The firm has a market cap of $197.54 billion, a PE ratio of 85.98, a P/E/G ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. During the same period last year, the firm earned $1.50 EPS. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on ISRG. Evercore ISI lowered their price target on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research report on Wednesday, April 23rd. Robert W. Baird decreased their target price on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Barclays dropped their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research report on Thursday, April 24th. Royal Bank of Canada reduced their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a “buy” rating in a report on Monday, April 14th. Five research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $596.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.